Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Current Oncology (Toronto, Ont.)|June 25, 2025
Evaluating the Impact of Common Non-Oncologic Medication Use During Radiotherapy in Patients with High-Risk Prostate CancerHaley K Perlow, Karishma Khullar, Ritesh Kumar, et al.
The Journal of Nutrition|September 14, 2024
Association between Inflammatory Dietary Pattern and Mammographic FeaturesShadi Azam, Sarah Asad, Saurabh D Chitnis, et al.
Scientific Reports|September 7, 2018
Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cellsKazumi Ebine, Krishan Kumar, Thao N Pham, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2021
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignanciesKatharine A Collier, Hugo Valencia, Herbert Newton, et al.
Laryngoscope Investigative Otolaryngology|October 20, 2021
Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomasD Bradley Welling, Katharine A Collier, Sarah S Burns, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
JCI Insight|March 9, 2026
Determinants of pancreatic tropism in metastatic renal cell carcinomaHaitao Xu, Payal Kapur, Alana Christie, et al.
Pageof 3